Tapewire

NYSE · USD

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC

Export transactions ↓
Tapewire entity
3234
SEC CIK
0000051253
Parsed reports
1,353

Last 12 months

Inside the activity.

9 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202512
Jan 202600
Feb 202610
Mar 202650
Apr 202600
May 202600
Jun 202620
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 06, 2023 Filed Apr 11, 2023 00:34 UTC Exercise / conversionPurchased Restricted Stock Units · Derivative 1,188 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004797 · doc4.xml · derivative · entry 3

Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,188 shares

Expires 2023-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Purchase Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis.

F3 · shares: Reflects vesting of PRSUs granted on May 4, 2022 pursuant to the Equity Choice Plan.

Read SEC document
April 06, 2023 Filed Apr 11, 2023 00:34 UTC Exercise / conversionCommon Stock 913 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004797 · doc4.xml · nonDerivative · entry 2

Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
April 06, 2023 Filed Apr 11, 2023 00:34 UTC Exercise / conversionCommon Stock 1,188 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004797 · doc4.xml · nonDerivative · entry 1

Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Purchase Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
April 06, 2023 Filed May 6, 2023 01:43 UTC
Yep Gregory LEVP, Chief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 2,665 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-005551 · doc4.xml · derivative · entry 3

Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,665 shares

Expires 2023-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan ("ECP").

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
April 06, 2023 Filed May 6, 2023 01:43 UTC
Yep Gregory LEVP, Chief Scientific Officer
Tax withholdingCommon Stock 733 $91.45 $67,032.85
Disclosure

SEC source: 0001225208-23-005551 · doc4.xml · nonDerivative · entry 2

Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,768

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
April 06, 2023 Filed May 6, 2023 01:43 UTC
Yep Gregory LEVP, Chief Scientific Officer
Exercise / conversionCommon Stock 2,665 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-005551 · doc4.xml · nonDerivative · entry 1

Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan ("ECP").

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:09 UTC GrantRestricted Stock Units · Derivative 262 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004498 · doc4.xml · derivative · entry 1

O'Byrne Kevin · CIK 0001969000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262

Underlying: Common Stock · 262 shares

Expires 2023-05-04

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
April 01, 2023 Filed Apr 5, 2023 20:08 UTC
Herriott SimonPresident Health & Biosciences
Exercise / conversionRestricted Stock Units · Derivative 1,489 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004674 · doc4.xml · derivative · entry 3

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,489

Underlying: Common Stock · 1,489 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F5 · derivative.exercise_date: The RSUs vested on April 1, 2023.

F5 · derivative.expiration_date: The RSUs vested on April 1, 2023.

Read SEC document
April 01, 2023 Filed Apr 5, 2023 20:08 UTC
Herriott SimonPresident Health & Biosciences
Tax withholdingCommon Stock 461 $90.60 $41,766.60
Disclosure

SEC source: 0001225208-23-004674 · doc4.xml · nonDerivative · entry 2

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,432.74

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

F4 · balance_after: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11.

Read SEC document
April 01, 2023 Filed Apr 5, 2023 20:08 UTC
Herriott SimonPresident Health & Biosciences
Exercise / conversionCommon Stock 1,489 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004674 · doc4.xml · nonDerivative · entry 1

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,893.74

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
March 24, 2023 Filed Mar 25, 2026 21:14 UTC
Costa Mark JDirector
PurchaseCommon Stock 10 $84.27 $842.70
Disclosure

SEC source: 0001225208-26-004019 · doc4.xml · nonDerivative · entry 1

Costa Mark J · CIK 0001364708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10

F1 · ownership.direct: During the periods presented, the Reporting Person inadvertently acquired and disposed of, as applicable, the number of shares and on the dates indicated above via automated transactions through a tax loss harvesting account. Such transactions were made under the Reporting Person's broker's (the "Broker") sole discretion and the Reporting Person had no control or authority over trading decisions. The Broker made the decisions to purchase and sell the subject shares and the Reporting Person was not aware of these very small transactions until recently. The result of these small transactions were losses for the Reporting Person.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:39 UTC GrantRestricted Stock Units · Derivative 434 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-003151 · doc4.xml · derivative · entry 1

Willoughby Dawn C · CIK 0001565196 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 434

Underlying: Common Stock · 434 shares

Expires 2023-05-04

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:38 UTC
Hu GaoxiangDirector
GrantRestricted Stock Units · Derivative 434 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-003150 · doc4.xml · derivative · entry 1

Hu Gaoxiang · CIK 0001839091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 434

Underlying: Common Stock · 434 shares

Expires 2023-05-04

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:38 UTC
Clyburn FrankChief Executive Officer
Exercise / conversionRestricted Deferred Stock Units · Derivative 1,323 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-003149 · doc4.xml · derivative · entry 3

Clyburn Frank · CIK 0001763963 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,296

Underlying: Common Stock · 1,323 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The DSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Deferred Restricted Stock Units ("DSUs") granted on March 1, 2022.

F2 · price: The DSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The DSUs vested on March 1, 2023.

F4 · derivative.expiration_date: The DSUs vested on March 1, 2023.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:38 UTC
Clyburn FrankChief Executive Officer
Tax withholdingCommon Stock 477 $91.64 $43,712.28
Disclosure

SEC source: 0001225208-23-003149 · doc4.xml · nonDerivative · entry 2

Clyburn Frank · CIK 0001763963 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 846

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of DSUs.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:38 UTC
Clyburn FrankChief Executive Officer
Exercise / conversionCommon Stock 1,323 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-003149 · doc4.xml · nonDerivative · entry 1

Clyburn Frank · CIK 0001763963 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,323

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Deferred Restricted Stock Units ("DSUs") granted on March 1, 2022.

F2 · price: The DSUs convert to Common Stock on a one-for-one basis.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:09 UTC
Herriott SimonPresident Health & Biosciences
Exercise / conversionRestricted Stock Units · Derivative 617 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002351 · doc4.xml · derivative · entry 3

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,978

Underlying: Common Stock · 617 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vested on February 19, 2023.

F4 · derivative.expiration_date: The RSUs vested on February 19, 2023.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:09 UTC
Herriott SimonPresident Health & Biosciences
Tax withholdingCommon Stock 177 $96.13 $17,015.01
Disclosure

SEC source: 0001225208-23-002351 · doc4.xml · nonDerivative · entry 2

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,367.756

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:09 UTC
Herriott SimonPresident Health & Biosciences
Exercise / conversionCommon Stock 617 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002351 · doc4.xml · nonDerivative · entry 1

Herriott Simon · CIK 0001843592 · President Health & Biosciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,544.756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Strzelecki AngelaPresident, Pharma Solutions
Exercise / conversionRestricted Stock Units · Derivative 584 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002348 · doc4.xml · derivative · entry 3

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,341

Underlying: Common Stock · 584 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vested on February 19, 2023.

F4 · derivative.expiration_date: The RSUs vested on February 19, 2023.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Strzelecki AngelaPresident, Pharma Solutions
Tax withholdingCommon Stock 176 $96.13 $16,918.88
Disclosure

SEC source: 0001225208-23-002348 · doc4.xml · nonDerivative · entry 2

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,077

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Strzelecki AngelaPresident, Pharma Solutions
Exercise / conversionCommon Stock 584 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002348 · doc4.xml · nonDerivative · entry 1

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Johnson Jennifer AmyEVP, General Counsel
Exercise / conversionRestricted Stock Units · Derivative 708 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002349 · doc4.xml · derivative · entry 3

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,041

Underlying: Common Stock · 708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vested on February 19, 2023.

F4 · derivative.expiration_date: The RSUs vested on February 19, 2023.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Johnson Jennifer AmyEVP, General Counsel
Tax withholdingCommon Stock 293 $96.13 $28,166.09
Disclosure

SEC source: 0001225208-23-002349 · doc4.xml · nonDerivative · entry 2

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,418

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 21:08 UTC
Johnson Jennifer AmyEVP, General Counsel
Exercise / conversionCommon Stock 708 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002349 · doc4.xml · nonDerivative · entry 1

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 21:06 UTC
Costa Mark JDirector
GrantRestricted Stock Units · Derivative 468 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001182 · doc4.xml · derivative · entry 1

Costa Mark J · CIK 0001364708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468

Underlying: Common Stock · 468 shares

Expires 2023-05-03

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
January 24, 2023 Filed Jan 25, 2023 21:06 UTC Exercise / conversionStock Equivalent Unit · Derivative 2,209.638 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000855 · doc4.xml · derivative · entry 2

DUCKER MICHAEL L · CIK 0001188170 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,209.638 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock.

F2 · shares: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan since the last report. The transactions were exempt pursuant to Rule 16a-11.

F1 · derivative.exercise_date: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock.

F1 · derivative.expiration_date: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock.

Read SEC document
January 24, 2023 Filed Jan 25, 2023 21:06 UTC Exercise / conversionCommon Stock 2,209.638 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000855 · doc4.xml · nonDerivative · entry 1

DUCKER MICHAEL L · CIK 0001188170 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,877.638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:27 UTC
Fortanet FranciscoEVP, Operations
Exercise / conversionPurchased Restricted Stock Units · Derivative 5,254 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000436 · doc4.xml · derivative · entry 4

Fortanet Francisco · CIK 0001351377 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,254 shares

Expires 2023-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:27 UTC
Fortanet FranciscoEVP, Operations
Tax withholdingCommon Stock 2,229 $103.11 $229,832.19
Disclosure

SEC source: 0001225208-23-000436 · doc4.xml · nonDerivative · entry 2

Fortanet Francisco · CIK 0001351377 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,262.729

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of PRSUs.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:27 UTC
Fortanet FranciscoEVP, Operations
Exercise / conversionCommon Stock 5,254 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000436 · doc4.xml · nonDerivative · entry 1

Fortanet Francisco · CIK 0001351377 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,491.729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan.

F2 · price: The PRSUs convert to Common Stock on a one-for-one basis.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:28 UTC
Strzelecki AngelaPresident, Pharma Solutions
Exercise / conversionRestricted Stock Units · Derivative 1,341 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000437 · doc4.xml · derivative · entry 3

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,925

Underlying: Common Stock · 1,341 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vested on January 3, 2023.

F4 · derivative.expiration_date: The RSUs vested on January 3, 2023.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:28 UTC
Strzelecki AngelaPresident, Pharma Solutions
Tax withholdingCommon Stock 487 $105.64 $51,446.68
Disclosure

SEC source: 0001225208-23-000437 · doc4.xml · nonDerivative · entry 2

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,669

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:28 UTC
Strzelecki AngelaPresident, Pharma Solutions
Exercise / conversionCommon Stock 1,341 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000437 · doc4.xml · nonDerivative · entry 1

Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,156

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:26 UTC Exercise / conversionRestricted Stock Units · Derivative 784 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000435 · doc4.xml · derivative · entry 2

Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 784 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Reflects vesting and settlement of RSUs granted on January 2, 2020.

F3 · derivative.exercise_date: The RSUs vested on January 2, 2023.

F3 · derivative.expiration_date: The RSUs vested on January 2, 2023.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:26 UTC Exercise / conversionCommon Stock 784 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000435 · doc4.xml · nonDerivative · entry 1

Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
December 31, 2022 Filed Jan 7, 2023 00:24 UTC
MIRZAYANTZ NICOLASPresident, Nourish
Disposition to issuerRestricted Stock Units · Derivative 1,843 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000466 · doc4.xml · derivative · entry 3

MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,701

Underlying: Common Stock · 1,843 shares

Expires 2024-05-05

F4 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · derivative.underlying_shares: Both PSUs and RSUs have been awarded by the Company pro rata in connection with the time the reporting person was with the Company, the rest were disposed of by the Company.

Read SEC document
December 31, 2022 Filed Jan 7, 2023 00:24 UTC
MIRZAYANTZ NICOLASPresident, Nourish
Disposition to issuerPurchased Restricted Stock Units · Derivative 1,962 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-000466 · doc4.xml · derivative · entry 2

MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,600

Underlying: Common Stock · 1,962 shares

Expires 2024-04-05

F1 · derivative.exercise_price: The Purchased Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represents matching grant of PRSUs under the Equity Choice Program, all of which would have vested on April 5, 2024.

F3 · derivative.underlying_shares: Both PSUs and RSUs have been awarded by the Company pro rata in connection with the time the reporting person was with the Company, the rest were disposed of by the Company.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 21:05 UTC
Finzel RalfEVP, Global Operations Officer
GrantRestricted Stock Units · Derivative 21,548 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-012165 · doc4.xml · derivative · entry 1

Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,548

Underlying: Common Stock · 21,548 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: 25% of each of the RSUs will vest on each of December 1, 2023 and December 1, 2024, and 50% will vest on December 1, 2025, in each case subject to the reporting person's continued employment with the Company.

F2 · derivative.expiration_date: 25% of each of the RSUs will vest on each of December 1, 2023 and December 1, 2024, and 50% will vest on December 1, 2025, in each case subject to the reporting person's continued employment with the Company.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:39 UTC GrantStock Equivalent Unit · Derivative 1,807.229 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011340 · doc4.xml · derivative · entry 2

MORRISON DALE F · CIK 0001179158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,876.949

Underlying: Common Stock · 1,807.229 shares

Expires not disclosed

F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis.

F2 · shares: Units under the Company's deferred compensation plan resulting from deferral of director fees.

F3 · derivative.exercise_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors.

F3 · derivative.expiration_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors.

F4 · balance_after: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan during 2022. The transactions were exempt pursuant to Rule 16a-11.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:33 UTC GrantStock Equivalent Unit · Derivative 1,178.628 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011328 · doc4.xml · derivative · entry 1

Williamson Stephen · CIK 0001648929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,562.883

Underlying: Common Stock · 1,178.628 shares

Expires not disclosed

F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis.

F2 · shares: Units under the Company's deferred compensation plan resulting from deferral of director fees.

F3 · derivative.exercise_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors.

F3 · derivative.expiration_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors.

F4 · balance_after: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan during 2022. The transactions were exempt pursuant to Rule 16a-11.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:29 UTC
Johnson Jennifer AmyEVP, General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,041 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011326 · doc4.xml · derivative · entry 3

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,749

Underlying: Common Stock · 1,041 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on November 1, 2021.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs vested on November 1, 2022.

F4 · derivative.expiration_date: The RSUs vested on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:29 UTC
Johnson Jennifer AmyEVP, General Counsel
Tax withholdingCommon Stock 376 $95.45 $35,889.20
Disclosure

SEC source: 0001225208-22-011326 · doc4.xml · nonDerivative · entry 2

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,003

F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:29 UTC
Johnson Jennifer AmyEVP, General Counsel
Exercise / conversionCommon Stock 1,041 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011326 · doc4.xml · nonDerivative · entry 1

Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on November 1, 2021.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
October 03, 2022 Filed Oct 4, 2022 20:16 UTC Exercise / conversionRestricted Stock Units · Derivative 11,812 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010684 · doc4.xml · derivative · entry 2

RICHTER GLENN R · CIK 0001200237 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,624

Underlying: Common Stock · 11,812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021.

F3 · derivative.exercise_date: The RSUs vested on October 1, 2022.

F3 · derivative.expiration_date: The RSUs vested on October 1, 2022.

Read SEC document
October 03, 2022 Filed Oct 4, 2022 20:16 UTC Exercise / conversionCommon Stock 11,812 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010684 · doc4.xml · nonDerivative · entry 1

RICHTER GLENN R · CIK 0001200237 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021.

F2 · price: The RSUs convert to Common Stock on a one-for-one basis.

Read SEC document
October 03, 2022 Filed Oct 4, 2022 20:11 UTC
Yildiz BerilCAO, SVP & Controller
GrantRestricted Stock Units · Derivative 2,155 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010681 · doc4.xml · derivative · entry 1

Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,155

Underlying: Common Stock · 2,155 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on October 3, 2023 and October 3, 2024, in each case subject to the reporting person's continued employment with the Company.

F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on October 3, 2023 and October 3, 2024, in each case subject to the reporting person's continued employment with the Company.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:24 UTC
Borg DeborahEVP, Chief HR and D&I Officer
GrantRestricted Stock Units · Derivative 4,602 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 3

Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,831

Underlying: Common Stock · 4,602 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: Represents RSUs granted under the Company's 2021 Stock Award and Incentive Plan, which vest and expire on April 4, 2025.

F3 · derivative.expiration_date: Represents RSUs granted under the Company's 2021 Stock Award and Incentive Plan, which vest and expire on April 4, 2025.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:24 UTC
Borg DeborahEVP, Chief HR and D&I Officer
GrantRestricted Stock Units · Derivative 9,205 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 2

Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,229

Underlying: Common Stock · 9,205 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025.

F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:24 UTC
Borg DeborahEVP, Chief HR and D&I Officer
GrantRestricted Stock Units · Derivative 46,024 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 1

Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,024

Underlying: Common Stock · 46,024 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025.

F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.